Clinical Trial Update: Strategies Towards Personalised Treatment in Juvenile Idiopathic Arthritis (JIA). [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating strategies toward personalized treatment in Juvenile Idiopathic Arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Idiopathic Arthritis

Snippet

Sponsor: Oslo University Hospital | Conditions: Juvenile Idiopathic Arthritis | Phase 4 | Status: COMPLETED